Funding for Research on Psychedelics Is on th...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ...  Show more

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ...  Show more

As interest and support for psychedelic research grows, scientists share their hopes for the future. Learn more about your ad choices. Visit megaphone.fm/adchoices 

James Gallagher reports on a psychedelic renaissance; a new wave of research testing hallucinogenic drugs like magic mushrooms to treat mental health conditions.There’s genuine excitement and some early encouraging evidence. A manufacturer tells James that in five years’ time, it ...  Show more

Drugs like ecstasy and mushrooms have shown promise as mental health treatments, but they’re also exposing some major cracks in how scientists study the brain. Guests: Jonathan Lambert, science journalist; Boris Heifets, professor at Stanford University of Medicine; Amy Mcguire, ...  Show more

There is growing support for psychedelics as performance enhancers, mood boosters, and a shortcut to therapy. The science is mixed. This episode was produced by Miles Bryan, engineered by Paul Mounsey, fact-checked by Victoria Dominguez, and edited by Matt Collette and host Sean ...  Show more